Hul-gsk Deal

Hindustan Unilever gets tax notice of Rs 962.75 cr over Rs 3k cr GSK deal

HUL has said that it has an 'indemnification right' to recover the demand raised by the Income Tax department

Global investors sell Unilever India stock as sales growth falters

The decline in Hindustan Unilever shares this year has helped improve its multiples. The stock is currently trading at 46 times its forward earnings, below its five-year average of about 54 times

HUL Q4 results preview: Here's what brokerage expect from the FMCG giant

According to analysts, the company's revenue and profit for the quarter under review may remain little changed as demand trends remain muted

HUL, GSK Asia to scrap distribution pact for OTC products by next year

In 2018, HUL had announced that GSK Consumer Healthcare will merge with HUL in an all-stock deal

HUL surges 4% after Societe Generale buys 12.9 million shares via bulk deal

On Thursday, UK-based Glaxo-SmithKline (GSK) offloaded its stake in HUL via block deals.

HUL, Dabur: Analysts bet on rural-focused FMCG stks amid Covid-19 lockdown

In the past month, HUL shares have gained 5 per cent, while Nestle (India) has risen 1 per cent in a falling market

GSK's health food drink Boost may get a brand refresh under new owner HUL

The health food drink may get a brand refresh under new owner HUL, as it readies to take on rivals such as Mondelez and Nestle in the category

HUL presents good opportunity to GSK shareholders; to add value in long run

Presence of latter in fast-growing segments to add value in long run

From Jefferies to Edelweiss, here's how brokerages interpret HUL-GSK deal

Here is a quick look at how various brokerages interpret the contours of the HUL-GSK Consumer deal and its impact on the other players in the FMCG space

With GSK buy, HUL also wins access to key pharmacy channels in India

Beauty and personal care sales contribution coming from the pharmacy channel is pegged at around 15-20%

Will $3.8 bn-worth HUL-GSK deal profit India unit? What analysts are saying

Shares in Hindustan Unilever rose 4.1 percent on Monday to a record, while GlaxoSmithKline Consumer Healthcare Ltd. added 2.8 percent to its highest level since Sept. 21

Unilever to buy Horlicks, other products for 3.3 bn euros in HUL-GSK merger

The merger of HUL with GSK Consumer Health will be on the basis of an exchange ratio of 4.39 HUL shares for each GSK Consumer Health share

HUL settles at record high, GSK Consumer up 4% after board approves merger

HUL settled 4.1% higher at Rs 1826 on the BSE. It had hit a new high of Rs 1,839 in intra-day trade, rising 4.9%, surpassing its previous high of Rs 1,808 touched on August 20, 2018

HUL-GSK deal proves the power of equity, role of premium valuations

In addition to iconic Horlicks brand for Indian as well as international markets, HUL would also own other brands such as Boost, Viva and Maltova

Deal with GSK Consumer Healthcare earnings accretive for Hindustan Unilever

The deal should help HUL expand its food and refreshment (F&R) segment

GSK minority shareholders must read fine print of merger with HUL: Experts

The all-equity merger of Hindustan Unilever Ltd with GSK Consumer Healthcare India appears tax neutral, say experts.

Around 4,000 GSK India employees face uncertain future after deal with HUL

Employees say they are unclear how many of them would be retained in HUL once the merger process gets over

A boost for Horlicks: Iconic brand to start life afresh under HUL

Under HUL, the iconic brand has to walk the tightrope between legacy and relevance, say experts

HUL, GSK ink Rs 317-bn merger in India's biggest consumer goods deal

HUL will become the largest food company in the country, with turnover of Rs 107 billion